Creoptix Inc.

https://www.creoptix.com

Creoptix is a private company headquartered in Wädenswil, near Zurich, Switzerland, and with US offices in the Boston area. Creoptix focuses on next-generation bioanalytical instruments for drug discovery and development as well as academic research. Based on its proprietary sensor and microfluidics technology, the Creoptix WAVE systems provide exceptionally high sensitivity and resolution in characterizing real-time interactions between small molecules, peptides, proteins and other molecules and even in crude samples like undiluted serum or plasma. *

	Start	2017-02-06 existent
	Group	Creoptix (Group)
	Today	Creoptix (Group)
	Industry	Creoptix WAVE system
	Industry 2	waveguide interferometry technology

	Region	Burlington, MA
	Country	United States (USA)
	Street	111 South Bedford Street c/o The Brighton Company, Suite 108
	City	01803 Burlington, MA
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Creoptix AG. (9/30/19). "Press Release: Creoptix Closes Successful Series C Financing Round to Support Further Growth". Wädenswil (Zurich).

		Record changed: 2019-10-01

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

Top News

Upcoming Events

Management Appointments

Financings & Acquisitions

Collaborations & Licensing

At Investor Conferences

Associations

Advertise

Creoptix Inc.